Related references
Note: Only part of the references are listed.Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases
Patrick G. Northup et al.
HEPATOLOGY (2021)
Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease
Fien A. von Meijenfeldt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Treatment of bleeding in patients with liver disease
Patrick G. Northup et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study
Arpan Mohanty et al.
LIVER INTERNATIONAL (2021)
Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
Annabel Blasi et al.
HEPATOLOGY (2020)
Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation
Amanda Bruder Rassi et al.
JOURNAL OF HEPATOLOGY (2020)
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
Ian Roberts et al.
LANCET (2020)
AGA Clinical Practice Update: Coagulation in Cirrhosis
Jacqueline G. O'Leary et al.
GASTROENTEROLOGY (2019)
Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis
Sarah Bos et al.
THROMBOSIS AND HAEMOSTASIS (2019)
In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis
Ton Lisman et al.
LIVER INTERNATIONAL (2018)
Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2017)
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases
Ton Lisman et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2017)
Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen
G. C. G. Hugenholtz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study
Federica Cerini et al.
HEPATOLOGY (2015)
Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: It is mostly ineffective, is expensive, and may rarely cause serious adverse events
Margaret S. Sozio et al.
HEPATOLOGY (2014)
Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding
Nicolas M. Intagliata et al.
LIVER INTERNATIONAL (2014)
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
Candid Villanueva et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
THROMBIN GENERATION IS NORMAL IN CIRRHOTICS WITH ACUTE VARICEAL HAEMORRHAGE: RESULTS FROM A PROSPECTIVE STUDY
V. Jairath et al.
GUT (2012)
Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma
Armando Tripodi et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial
Jaime Bosch et al.
HEPATOLOGY (2008)